U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Rb
Molecular Weight 85.4678
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of RUBIDIUM CATION

SMILES

[Rb+]

InChI

InChIKey=NCCSSGKUIKYAJD-UHFFFAOYSA-N
InChI=1S/Rb/q+1

HIDE SMILES / InChI

Molecular Formula Rb
Molecular Weight 85.4678
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/3311597 | https://www.ncbi.nlm.nih.gov/pubmed/26442267

Rubidium chloride is an inorganic compound with the formula RbCl. It appears to be nontoxic and therapeutically effective in several types of depressive disorders. This drug develops his action on dopaminergic stimulation reducing the depressive pattern. Also radioactive rubidium-82 chloride is used as diagnostic agent in positron emission tomography (PET).

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
RUBINORM

Approved Use

Depression
PubMed

PubMed

TitleDatePubMed
Protein kinase C-epsilon modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells.
2004-02
Gating properties of inward-rectifier potassium channels: effects of permeant ions.
2001-11-01
Inhibition of HIV-1 infection by zinc group metal compounds.
1999-09
Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study.
1999-05
Exploration of the clinical profile of rubidium chloride in depression: a systematic open trial.
1988-06
Nerve fibre refractory period in patients treated with rubidium and lithium.
1978-09
Effects of rubidium chloride on the course of manic-depressive illness.
1978-05
Rubidium chloride ingestion by volunteer subjects: initial experience.
1971
Brain norepinephrine: enhanced turnover after rubidium treatment.
1970-04-24
Patents

Sample Use Guides

540 mg/day
Route of Administration: Oral
In Vitro Use Guide
Rubidium chloride accelerated cAMP synthesis in rat brain cortex membranes. The effect was dose-dependent and yielded above 2-fold activation of adenylate cyclase. It has been shown that Rb+ influenced directly the catalytic subunit of the enzyme and did not substitute Mg2+ in formation of the metal-ATP complex in this reaction. The stimulatory effect of Rb+ was additive to the activation of adenylate cyclase by the half-maximal (0.3 microM) as well as by the saturating (10 microM) forskolin concentrations, pointing to the fact that these effectors activate different isoforms of the enzyme in rat brain cortex.
Substance Class Chemical
Created
by admin
on Wed Apr 02 11:27:41 GMT 2025
Edited
by admin
on Wed Apr 02 11:27:41 GMT 2025
Record UNII
PR87B22TGJ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RUBIDIUM ION
Preferred Name English
RUBIDIUM CATION
Common Name English
RUBIDIUM ION(1+)
Common Name English
RUBIDIUM(1+)
Systematic Name English
RUBIDIUM, ION (RB1+)
Systematic Name English
Code System Code Type Description
PUBCHEM
105153
Created by admin on Wed Apr 02 11:27:41 GMT 2025 , Edited by admin on Wed Apr 02 11:27:41 GMT 2025
PRIMARY
CHEBI
49847
Created by admin on Wed Apr 02 11:27:41 GMT 2025 , Edited by admin on Wed Apr 02 11:27:41 GMT 2025
PRIMARY
EPA CompTox
DTXSID50177059
Created by admin on Wed Apr 02 11:27:41 GMT 2025 , Edited by admin on Wed Apr 02 11:27:41 GMT 2025
PRIMARY
FDA UNII
PR87B22TGJ
Created by admin on Wed Apr 02 11:27:41 GMT 2025 , Edited by admin on Wed Apr 02 11:27:41 GMT 2025
PRIMARY
CAS
22537-38-8
Created by admin on Wed Apr 02 11:27:41 GMT 2025 , Edited by admin on Wed Apr 02 11:27:41 GMT 2025
PRIMARY
DAILYMED
PR87B22TGJ
Created by admin on Wed Apr 02 11:27:41 GMT 2025 , Edited by admin on Wed Apr 02 11:27:41 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY